Simplify Logo

Full-Time

Manager – Accounting

Posted on 7/25/2024

Adaptive Biotechnologies

Adaptive Biotechnologies

501-1,000 employees

Decodes immune cell receptors for diagnostics

Hardware
Biotechnology
Healthcare

Compensation Overview

$100.6k - $150.8kAnnually

+ Equity Grants + Bonuses

Senior, Expert

Seattle, WA, USA

Category
Financial Controller
Accounting
Requirements
  • BA/BS degree in Accounting, Finance, or equivalent
  • CPA or equivalent certification preferred
  • 8+ years’ experience; experience in a Big 4 public accounting firm, public company, or equivalent preferred
  • Excellent understanding of US-GAAP, FASB codification, SEC reporting requirements and a broad knowledge of technical accounting matters
  • Experience working in the Life Sciences, Biotechnology, Research & Development, or Medical Device industries preferred
  • Strong people leadership skills and ability to coach, mentor, and develop future leaders
  • Excellent verbal and written communication skills
  • Ability to work effectively and constructively in a team environment
  • Excited about a collaborative team environment and driven to make a difference
Responsibilities
  • Develop and manage a high-performing team
  • Set high-impact team goals in alignment with corporate goals
  • Review and oversight of accounting workpapers
  • Identify and interpret trends and explain fluctuations
  • Work cross-functionally to support and oversee process changes
  • Support the preparation of company financial statements
  • Engage with internal and external auditors
  • Document accounting positions on complex matters
  • Provide technical accounting oversight for control design
  • Support business development activities
  • Provide oversight to accounting projects and team members
  • Address complex inquiries from teammates and customers
  • Educate other finance team members on technical accounting matters
Adaptive Biotechnologies

Adaptive Biotechnologies

View

Adaptive Biotechnologies focuses on using the immune system to improve disease diagnosis and treatment. The company decodes genetic information from immune cell receptors, which are essential for the immune system's ability to identify and respond to diseases. One of their key projects is the ImmuneRACE study, which analyzes blood samples and swabs from participants to understand how the immune system reacts to COVID-19. This research aims to enhance diagnostics, treatments, and vaccines for the virus. Adaptive Biotechnologies generates revenue by partnering with pharmaceutical companies, licensing their technology, and offering diagnostic services. Their goal is to leverage immune system data to advance healthcare solutions for various diseases.

Company Stage

IPO

Total Funding

$575.5M

Headquarters

Seattle, Washington

Founded

2009

Growth & Insights
Headcount

6 month growth

-4%

1 year growth

-8%

2 year growth

-10%
Simplify Jobs

Simplify's Take

What believers are saying

  • Adaptive Biotechnologies' partnerships with pharmaceutical companies and healthcare providers offer significant growth opportunities and revenue streams.
  • Winning the Workplace of the Year Award highlights their strong company culture and employee satisfaction, making it an attractive place to work.
  • Their collaboration with BeiGene on minimal residual disease measurement could lead to groundbreaking advancements in cancer treatment.

What critics are saying

  • The departure of key board members like Kevin Conroy and Leslie Trigg could lead to strategic instability.
  • The highly competitive biotechnology sector requires continuous innovation to maintain market position.

What makes Adaptive Biotechnologies unique

  • Adaptive Biotechnologies leverages the genetic information of immune cell receptors to develop advanced diagnostic tools and treatments, setting it apart from traditional biotech firms.
  • Their ImmuneRACE study, focusing on COVID-19 immune response, showcases their commitment to addressing current global health challenges.
  • The integration of their clonoSEQ® assay with Epic systems enhances their diagnostic capabilities, providing a seamless experience for healthcare providers.
INACTIVE